Georgia's Online Cancer Information Center

Find A Clinical Trial

Phase II Randomized Placebo-Controlled Clinical Trial of Genistein in Reducing the Toxicity and Improving the Efficacy of Intravesical Therapy

Cancer Type
Bladder Cancer
Trial Phase
Phase II
18 Years and older, Male and Female
Study Type
Protocol IDs
EU2010-11 (primary)
Study Sponsor
Emory University Hospital / Winship Cancer Institute


This randomized phase II trial studies how well genistein works in reducing the toxicity and improving the efficacy of Bacillus Calmette Guerin intravesical (within the bladder) therapy in patients with bladder cancer. Genistein may reduce adverse urinary tract symptoms due to inflammation from intravesical therapy and improve the quality of life of patients with bladder cancer. Genistein may also stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.


I. The change in severity of urinary symptoms over time as determined by the International Prognostic Scoring System (IPSS) questionnaire score, specifically comparing the symptoms at the 1st Bacillus Calmette Guerin (BCG) treatment (baseline) to the symptoms at the 6th week of treatment.

I. The presence of cancer and the rate of recurrence as determined by the 10-week biopsy or subsequent standard follow-up visits.
II. The total dose of intravesical therapy administered over the 6 weeks of treatment.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients receive placebo orally (PO) three times daily (TID) for 10 weeks.

ARM II: Patients receive genistein PO TID for 10 weeks.

After completion of study treatment, patients are followed up for 1 month.

Treatment Sites in Georgia

Emory Saint Joseph's Hospital

5665 Peachtree Dunwoody Road NE
Atlanta, GA 30342

Emory University Hospital - Atlanta

1364 Clifton Road NE
Atlanta, GA 30322

Emory University Hospital - Midtown

550 Peachtree Street NE
Atlanta, GA 30308

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.